Thanaporn Thamrongjirapat
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.
Journal: Frontiers in oncology
Published: January 14, 2026
The impact of systemic inflammatory markers on EGFR-mutant non-small cell lung cancer.
Journal: BMC cancer
Published: April 12, 2025
Changing Landscape of Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma Treatment and Survival Trends in Thailand: A 13-Year Multicenter Retrospective Study of Patients.
Journal: JCO global oncology
Published: January 08, 2025
Dynamic changes in immune repertoire profiles in patients with stage III unresectable non-small cell lung cancer during consolidation treatment with immunotherapy.
Journal: BMC cancer
Published: September 05, 2023
Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.
Journal: BMC cancer
Published: August 28, 2023
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients.
Journal: Frontiers in pharmacology
Published: May 14, 2023
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.
Journal: Frontiers in oncology
Published: September 28, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026